{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:18:14Z","timestamp":1772165894856,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Japan Agency for Medical Research and Developmen","award":["24mk0121256h0502"],"award-info":[{"award-number":["24mk0121256h0502"]}]},{"name":"the Japan Agency for Medical Research and Developmen","award":["24mk0121256h0502"],"award-info":[{"award-number":["24mk0121256h0502"]}]},{"name":"the Japan Agency for Medical Research and Developmen","award":["24mk0121256h0502"],"award-info":[{"award-number":["24mk0121256h0502"]}]},{"name":"the Japan Agency for Medical Research and Developmen","award":["24mk0121256h0502"],"award-info":[{"award-number":["24mk0121256h0502"]}]},{"name":"the Japan Agency for Medical Research and Developmen","award":["24mk0121256h0502"],"award-info":[{"award-number":["24mk0121256h0502"]}]},{"name":"the Japan Agency for Medical Research and Developmen","award":["24mk0121256h0502"],"award-info":[{"award-number":["24mk0121256h0502"]}]},{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"crossref","award":["243fa627003h0003"],"award-info":[{"award-number":["243fa627003h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"crossref","award":["243fa627003h0003"],"award-info":[{"award-number":["243fa627003h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"crossref","award":["243fa627003h0003"],"award-info":[{"award-number":["243fa627003h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"crossref","award":["243fa627003h0003"],"award-info":[{"award-number":["243fa627003h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"crossref","award":["243fa627003h0003"],"award-info":[{"award-number":["243fa627003h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"crossref","award":["243fa627003h0003"],"award-info":[{"award-number":["243fa627003h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Intractable Respiratory Diseases and Pulmonary Hypertension Research Group, Ministry of Health, Labor and Welfare, Japan","award":["20FC1027"],"award-info":[{"award-number":["20FC1027"]}]},{"name":"the Intractable Respiratory Diseases and Pulmonary Hypertension Research Group, Ministry of Health, Labor and Welfare, Japan","award":["20FC1027"],"award-info":[{"award-number":["20FC1027"]}]},{"name":"the Intractable Respiratory Diseases and Pulmonary Hypertension Research Group, Ministry of Health, Labor and Welfare, Japan","award":["20FC1027"],"award-info":[{"award-number":["20FC1027"]}]},{"name":"the Intractable Respiratory Diseases and Pulmonary Hypertension Research Group, Ministry of Health, Labor and Welfare, Japan","award":["20FC1027"],"award-info":[{"award-number":["20FC1027"]}]},{"name":"the Intractable Respiratory Diseases and Pulmonary Hypertension Research Group, Ministry of Health, Labor and Welfare, Japan","award":["20FC1027"],"award-info":[{"award-number":["20FC1027"]}]},{"name":"the Intractable Respiratory Diseases and Pulmonary Hypertension Research Group, Ministry of Health, Labor and Welfare, Japan","award":["20FC1027"],"award-info":[{"award-number":["20FC1027"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-024-03184-6","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T03:46:41Z","timestamp":1722224801000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Serum stratifin measurement is useful for evaluating disease severity and outcomes in patients with acute exacerbation of interstitial lung disease: a retrospective study"],"prefix":"10.1186","volume":"24","author":[{"given":"Noriko","family":"Sakuma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriaki","family":"Arakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Matsuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiro","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuji","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Tatsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,29]]},"reference":[{"key":"3184_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1164\/rccm.201604-0801CI","volume":"194","author":"HR Collard","year":"2016","unstructured":"Collard HR, Ryerson CJ, Corte TJ, Jenkins G, Kondoh Y, Lederer DJ, et al. Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report. Am J Respir Crit Care Med. 2016;194:265\u201375.","journal-title":"Am J Respir Crit Care Med."},{"key":"3184_CR2","first-page":"103","volume":"27","author":"Y Kondoh","year":"2010","unstructured":"Kondoh Y, Taniguchi H, Katsuta T, Kataoka K, Kimura T, Nishiyama O, et al. Risk factors of acute exacerbation of idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis. 2010;27:103\u201310.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"3184_CR3","doi-asserted-by":"publisher","first-page":"180100","DOI":"10.1183\/16000617.0100-2018","volume":"28","author":"V Cottin","year":"2019","unstructured":"Cottin V, Wollin L, Fischer A, Quaresma M, Stowasser S, Harari S. Fibrosing interstitial lung diseases: knowns and unknowns. Eur Respir Rev. 2019;28:180100.","journal-title":"Eur Respir Rev"},{"key":"3184_CR4","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","volume":"205","author":"G Raghu","year":"2022","unstructured":"Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, et al. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an Official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2022;205:e18\u201347.","journal-title":"Am J Respir Crit Care Med"},{"key":"3184_CR5","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/resp.13682","volume":"25","author":"A Suzuki","year":"2020","unstructured":"Suzuki A, Kondoh Y, Brown KK, Johkoh T, Kataoka K, Fukuoka J, et al. Acute exacerbations of fibrotic interstitial lung diseases. Respirology. 2020;25:525\u201334.","journal-title":"Respirology"},{"key":"3184_CR6","doi-asserted-by":"publisher","first-page":"e000212","DOI":"10.1136\/bmjresp-2017-000212","volume":"4","author":"KR Flaherty","year":"2017","unstructured":"Flaherty KR, Brown KK, Wells AU, Clerisme-Beaty E, Collard HR, Cottin V, et al. Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease. BMJ Open Respir Res. 2017;4:e000212.","journal-title":"BMJ Open Respir Res"},{"key":"3184_CR7","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1164\/ajrccm.162.3.9910080","volume":"162","author":"H Takahashi","year":"2000","unstructured":"Takahashi H, Fujishima T, Koba H, Murakami S, Kurokawa K, Shibuya Y, et al. Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am J Respir Crit Care Med. 2000;162:1109\u201314.","journal-title":"Am J Respir Crit Care Med"},{"key":"3184_CR8","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1164\/ajrccm.165.3.2107134","volume":"165","author":"H Ohnishi","year":"2002","unstructured":"Ohnishi H, Yokoyama A, Kondo K, Hamada H, Abe M, Nishimura K, et al. Comparative study of KL-6, surfactant protein-a, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. Am J Respir Crit Care Med. 2002;165:378\u201381.","journal-title":"Am J Respir Crit Care Med"},{"key":"3184_CR9","doi-asserted-by":"publisher","first-page":"L3","DOI":"10.1152\/ajplung.90637.2008","volume":"299","author":"HR Collard","year":"2010","unstructured":"Collard HR, Calfee CS, Wolters PJ, Song JW, Hong SB, Brady S, et al. Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2010;299:L3\u20137.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"3184_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S1097-2765(00)80002-7","volume":"1","author":"H Hermeking","year":"1997","unstructured":"Hermeking H, Lengauer C, Polyak K, He TC, Zhang L, Thiagalingam S, et al. 14-3-3sigma is a p53-regulated inhibitor of G2\/M progression. Mol Cell. 1997;1:3\u201311.","journal-title":"Mol Cell"},{"key":"3184_CR11","doi-asserted-by":"publisher","first-page":"23106","DOI":"10.1074\/jbc.M905616199","volume":"275","author":"C Laronga","year":"2000","unstructured":"Laronga C, Yang HY, Neal C, Lee MH. Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression. J Biol Chem. 2000;275:23106\u201312.","journal-title":"J Biol Chem"},{"key":"3184_CR12","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1002\/ijc.25907","volume":"129","author":"A Shiba-Ishii","year":"2011","unstructured":"Shiba-Ishii A, Kano J, Morishita Y, Sato Y, Minami Y, Noguchi M. High expression of stratifin is a universal abnormality during the course of malignant progression of early-stage lung adenocarcinoma. Int J Cancer. 2011;129:2445\u201353.","journal-title":"Int J Cancer"},{"key":"3184_CR13","doi-asserted-by":"publisher","first-page":"5854","DOI":"10.1038\/s41467-022-33160-9","volume":"13","author":"N Arakawa","year":"2022","unstructured":"Arakawa N, Ushiki A, Abe M, Matsuyama S, Saito Y, Kashiwada T, et al. Stratifin as a novel diagnostic biomarker in serum for diffuse alveolar damage. Nat Commun. 2022;13:5854.","journal-title":"Nat Commun"},{"key":"3184_CR14","doi-asserted-by":"publisher","first-page":"684","DOI":"10.7326\/0003-4819-156-10-201205150-00004","volume":"156","author":"B Ley","year":"2012","unstructured":"Ley B, Ryerson C, Vittinghoff E, et al. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med. 2012;156:684\u201391.","journal-title":"Ann Intern Med"},{"key":"3184_CR15","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/44188","volume":"401","author":"TA Chan","year":"1999","unstructured":"Chan TA, Hermeking H, Lengauer C, Kinzler KW, Vogelstein B. 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage. Nature. 1999;401:616\u201320.","journal-title":"Nature"},{"key":"3184_CR16","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1083\/jcb.149.5.1117","volume":"149","author":"E Dellambra","year":"2000","unstructured":"Dellambra E, Golisano O, Bondanza S, Siviero E, Lacal P, Molinari M, et al. Downregulation of 14-3-3sigma prevents clonal evolution and leads to immortalization of primary human keratinocytes. J Cell Biol. 2000;149:1117\u201330.","journal-title":"J Cell Biol"},{"key":"3184_CR17","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/j.ajpath.2011.12.014","volume":"180","author":"A Shiba-Ishii","year":"2012","unstructured":"Shiba-Ishii A, Noguchi M. Aberrant stratifin overexpression is regulated by tumor-associated CpG demethylation in lung adenocarcinoma. Am J Pathol. 2012;180:1653\u201362.","journal-title":"Am J Pathol"},{"key":"3184_CR18","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1038\/sj.onc.1204252","volume":"20","author":"WR Taylor","year":"2001","unstructured":"Taylor WR, Stark GR. Regulation of the G2\/M transition by p53. Oncogene. 2001;20:1803\u201315.","journal-title":"Oncogene"},{"key":"3184_CR19","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s11010-007-9538-y","volume":"305","author":"A Medina","year":"2007","unstructured":"Medina A, Ghaffari A, Kilani RT, Ghahary A. The role of stratifin in fibroblast-keratinocyte interaction. Mol Cell Biochem. 2007;305:255\u201364.","journal-title":"Mol Cell Biochem"},{"key":"3184_CR20","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1164\/rccm.201403-0566OC","volume":"190","author":"M Natsuizaka","year":"2014","unstructured":"Natsuizaka M, Chiba H, Kuronuma K, Otsuka M, Kudo K, Mori M, et al. Epidemiologic survey of Japanese patients with idiopathic pulmonary fibrosis and investigation of ethnic differences. Am J Respir Crit Care Med. 2014;190:773\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"3184_CR21","doi-asserted-by":"publisher","first-page":"665","DOI":"10.2217\/bmm-2019-0545","volume":"14","author":"M D\u2019Alessandro","year":"2020","unstructured":"D\u2019Alessandro M, Bergantini L, Cameli P, Vietri L, Lanzarone N, Alonzi V, et al. Krebs von den Lungen-6 as a biomarker for disease severity assessment in interstitial lung disease: a comprehensive review. Biomark Med. 2020;14:665\u201374.","journal-title":"Biomark Med"},{"key":"3184_CR22","doi-asserted-by":"publisher","first-page":"e0255365","DOI":"10.1371\/journal.pone.0255365","volume":"16","author":"JH Lee","year":"2021","unstructured":"Lee JH, Jang JH, Park JH, Jang HJ, Park CS, Lee S, et al. The role of interleukin-6 as a prognostic biomarker for predicting acute exacerbation in interstitial lung diseases. PLoS One. 2021;16:e0255365.","journal-title":"PLoS One"},{"key":"3184_CR23","doi-asserted-by":"publisher","first-page":"739","DOI":"10.21037\/atm-21-414","volume":"9","author":"H Shimizu","year":"2021","unstructured":"Shimizu H, Sakamoto S, Okamoto M, Isshiki T, Ono J, Shimizu S, et al. Association of serum monomeric periostin level with outcomes of acute exacerbation of idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia. Ann Transl Med. 2021;9:739.","journal-title":"Ann Transl Med"},{"key":"3184_CR24","doi-asserted-by":"publisher","first-page":"5346","DOI":"10.21037\/jtd.2018.08.60","volume":"10","author":"T Nikaido","year":"2018","unstructured":"Nikaido T, Tanino Y, Wang X, Sato Y, Togawa R, Kikuchi M, et al. Serum decorin is a potential prognostic biomarker in patients with acute exacerbation of idiopathic pulmonary fibrosis. J Thorac Dis. 2018;10:5346\u201358.","journal-title":"J Thorac Dis"},{"key":"3184_CR25","doi-asserted-by":"publisher","first-page":"e0176789","DOI":"10.1371\/journal.pone.0176789","volume":"12","author":"Y Sato","year":"2017","unstructured":"Sato Y, Tanino Y, Wang X, Nikaido T, Sato S, Misa K, et al. Baseline serum syndecan-4 predicts prognosis after the onset of acute exacerbation of idiopathic interstitial pneumonia. PLoS One. 2017;12:e0176789.","journal-title":"PLoS One"},{"key":"3184_CR26","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.resinv.2017.06.001","volume":"55","author":"M Tominaga","year":"2017","unstructured":"Tominaga M, Okamoto M, Kawayama T, Matsuoka M, Kaieda S, Sakazaki Y, et al. Overexpression of IL-38 protein in anticancer drug-induced lung injury and acute exacerbation of idiopathic pulmonary fibrosis. Respir Investig. 2017;55:293\u20139.","journal-title":"Respir Investig"},{"key":"3184_CR27","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.intimp.2019.02.039","volume":"70","author":"X Gui","year":"2019","unstructured":"Gui X, Qiu X, Tian Y, Xie M, Li H, Gao Y, et al. Prognostic value of IFN-\u03b3, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis. Int Immunopharmacol. 2019;70:208\u201315.","journal-title":"Int Immunopharmacol"},{"key":"3184_CR28","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.cyto.2017.08.019","volume":"102","author":"SA Papiris","year":"2018","unstructured":"Papiris SA, Tomos IP, Karakatsani A, Spathis A, Korbila I, Analitis A, et al. High levels of IL-6 and IL-8 characterize early-on idiopathic pulmonary fibrosis acute exacerbations. Cytokine. 2018;102:168\u201372.","journal-title":"Cytokine"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-024-03184-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-024-03184-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-024-03184-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T03:47:05Z","timestamp":1722224825000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-024-03184-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,29]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3184"],"URL":"https:\/\/doi.org\/10.1186\/s12890-024-03184-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3865212\/v1","asserted-by":"object"}]},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,29]]},"assertion":[{"value":"15 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The clinical trial research protocol was approved by the Human Ethics Committee of Chiba University Hospital (approval number: 2083 and 2265) and complied with the Declaration of Helsinki Ethical Principles for medical research involving human subjects. We obtained written informed consent from all the patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.\u00a0NA and YS are inventors of patents related to stratifin involved in the diagnosis of ILD as filed by the National Institute of Health Science.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"364"}}